This post looks at the suspicious activities seen at the Kyobo account on SK Biosciences' Day 1 and Day 2 and what it can mean for the price in the immediate term.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.